XBiotech Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $125.6M | $172.7M | $200.0M | $157.3M | $237.0M | $237.4M | $714.6M | $15.8M |
| Accounts Receivable | — | — | — | — | $0 | $4.1M | $0 | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $127.0M | $174.6M | $201.7M | $219.8M | $246.9M | $325.9M | $716.3M | $17.0M |
| Property, Plant & Equipment | $23.1M | $24.5M | $24.9M | $26.3M | $28.3M | $27.3M | $25.2M | $27.3M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $150.1M | $199.1M | $226.6M | $246.1M | $275.2M | $353.7M | $816.9M | $44.3M |
| Liabilities | ||||||||
| Accounts Payable | $1.5M | $2.2M | $2.5M | $2.4M | $2.1M | $2.5M | $2.1M | $1.7M |
| Total Current Liabilities | $7.9M | $15.1M | $6.1M | $4.1M | $3.5M | $4.0M | $60.2M | $2.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $9.7M | $16.8M | $7.8M | $5.7M | $5.8M | $5.1M | $61.2M | $2.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-136.4M | $-90.8M | $-52.3M | $-27.7M | $5.2M | $97.6M | $430.9M | $-237.7M |
| Total Stockholders' Equity | $140.4M | $182.3M | $218.8M | $240.4M | $269.4M | $348.6M | $755.6M | $41.4M |